ter Horst Simone A J, Fijlstra Margot, Sengupta Sujata, Walther Frans J, Wagenaar Gerry T M
Division of Neonatology, Department of Pediatrics, Leiden University Medical Center, J6-S, Albinusdreef 2, 2333 ZA Leiden, The Netherlands.
BMC Pulm Med. 2006 Apr 18;6:8. doi: 10.1186/1471-2466-6-8.
Bronchopulmonary dysplasia, a complex chronic lung disease in premature children in which oxidative stress and surfactant deficiency play a crucial role, is characterized by arrested alveolar and vascular development of the immature lung. The spatial and temporal patterns of expression of surfactant proteins are not yet fully established in newborn infants and animal models suffering from BPD.
We studied the mRNA expression of surfactant proteins (SP) A, -B, -C and -D and Clara cell secretory protein (CC10) with RT-PCR and in situ hybridization and protein expression of CC10, SP-A and -D with immunohistochemistry in the lungs of a preterm rat model, in which experimental BPD was induced by prolonged oxidative stress.
Gene expression of all surfactant proteins (SP-A, -B, -C and -D) was high at birth and initially declined during neonatal development, but SP-A, -B, and -D mRNA levels increased during exposure to hyperoxia compared to room-air controls. Peak levels were observed in adult lungs for SP-A, SP-C and CC10. Except for SP-A, the cellular distribution of SP-B, -C, -D and CC10, studied with in situ hybridization and/or immunohistochemistry, did not change in room air nor in hyperoxia. Exposure to normoxia was associated with high levels of SP-A mRNA and protein in alveolar type 2 cells and low levels in bronchial Clara cells, whereas hyperoxia induced high levels of SP-A expression in bronchial Clara cells.
The increased expression of SP-A mRNA under hyperoxia can be attributed, at least in part, to an induction of mRNA and protein expression in bronchial Clara cells. The expanded role of Clara cells in the defence against hyperoxic injury suggests that they support alveolar type 2 cell function and may play an important role in the supply of surfactant proteins to the lower airways.
支气管肺发育不良是一种早产儿复杂的慢性肺部疾病,氧化应激和表面活性剂缺乏在其中起关键作用,其特征是未成熟肺的肺泡和血管发育停滞。在患有支气管肺发育不良的新生儿和动物模型中,表面活性剂蛋白表达的时空模式尚未完全明确。
我们采用逆转录聚合酶链反应(RT-PCR)和原位杂交技术研究了表面活性剂蛋白(SP)A、-B、-C和-D以及克拉拉细胞分泌蛋白(CC10)的mRNA表达,并采用免疫组织化学技术研究了CC10、SP-A和-D在早产大鼠模型肺中的蛋白表达,该模型通过长期氧化应激诱导实验性支气管肺发育不良。
所有表面活性剂蛋白(SP-A、-B、-C和-D)的基因表达在出生时较高,在新生儿发育初期下降,但与空气对照组相比,在高氧暴露期间SP-A、-B和-D的mRNA水平升高。SP-A、SP-C和CC10在成年肺中观察到峰值水平。除SP-A外,通过原位杂交和/或免疫组织化学研究的SP-B、-C、-D和CC10的细胞分布在空气和高氧环境中均未改变。暴露于常氧与肺泡Ⅱ型细胞中高水平的SP-A mRNA和蛋白以及支气管克拉拉细胞中的低水平相关,而高氧诱导支气管克拉拉细胞中高水平的SP-A表达。
高氧条件下SP-A mRNA表达的增加至少部分归因于支气管克拉拉细胞中mRNA和蛋白表达的诱导。克拉拉细胞在抵御高氧损伤中的作用扩大表明它们支持肺泡Ⅱ型细胞功能,并且可能在向较低气道供应表面活性剂蛋白中起重要作用。